Alembic Pharma gets USFDA nod for Phytonadione Injectable Emulsion for hypoprothrombinemia due to vitamin K deficiency
Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phytonadione Injectable…
Alembic Pharma surges over 12% on USFDA approval for Cancer drug
Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food…
Neutral Alembic Pharma; target of Rs 930: Motilal Oswal
Motilal Oswal’s research report on Alembic Pharma Alembic Pharma (ALPM) delivered a better-than-expected performance in 4QFY25. A strong performance in export markets was offset partly by a muted show in…
Alembic Pharma Receives Four Observations From U.S. FDA For Panelav Facility
Earlier on Monday, U.S. health regulator has conducted an inspection at it Panelav facility in Gujarat and issued Form 483 with four procedural observations according to Alembic Pharmaceuticals. “The U.S.…
Pharma sector business in US is going to be the most profitable
– Analysts expect sales to grow by around 15 percent in the first quarter of the fiscal year 2019-2020 led by sales in the US market. – US sales are likely…
